← SynDRA
ARGLABIN
SynDRA canonical compound SYN0034325 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | NFKB1 |
|---|
| Mechanism of action | Farnesyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Farnesyltransferase inhibitor
Cross-references
Synonyms
- AC1LCSV4
- SCHEMBL15527919
- DTXSID30233687
- ZINC6634471
- ACN-035850
- (+)-arglabin
- YS8UOP7QZ1
- CHEBI:73228
- RefChem:113990
- DTXCID60156178
- Arglabin=DMA
- UNII-YS8UOP7QZ1
- MFCD28716120
- ARGLABINE
- (+)-Arglabin?
- SCHEMBL60010
- orb1296162
- GLXC-20521
- BDBM50433455
- AKOS030485961
- EBC-510763
- NCGC00390770-01
- AC-37608
- DA-61201
- HY-16059
- MS-23492
- A3449
- BRD-K62734952-001-01-0
- 1beta,10beta-epoxyguaia-3,11(13)-dien-12,6alpha-olide
- アルグラビン
- 亮绿蒿素
Look up ARGLABIN in the interactive SynDRA portal →